Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabotegravir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03149848
What this trial is testing

Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 15
Large-scale testing (Phase 3)Study completedNCT05601128
What this trial is testing

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Who this might be right for
HIV-1-infectionHIV InfectionsHIV I Infection
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 12
Not applicableNot Yet RecruitingNCT07620730
What this trial is testing

PrEP-LANA (Pre-exposure Prophylaxis- Long-acting Novel Antiviral Agent)

Who this might be right for
PrEPPrEP Adherence ExperiencesPrEP Adherence Perspectives+3 more
Queen Mary University of London 220
Post-approval studies (Phase 4)WithdrawnNCT05156658
What this trial is testing

Pharmacokinetic Interactions of ENG Subdermal Implants with Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA)

Who this might be right for
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Large-scale testing (Phase 3)Active Not RecruitingNCT05546242
What this trial is testing

Improving HIV-1 Control in Africa with Long Acting Antiretrovirals

Who this might be right for
HIV-1-infection
MRC/UVRI and LSHTM Uganda Research Unit 540
Early research (Phase 1)Study completedNCT01467531
What this trial is testing

Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

Who this might be right for
Infections, Human Immunodeficiency Virus and Hepatitis
ViiV Healthcare 28
Early research (Phase 1)Study completedNCT05112939
What this trial is testing

A Rilpivirine Extended-Release Suspension in Healthy Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 126
Testing effectiveness (Phase 2)Study completedNCT03497676
What this trial is testing

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Large-scale testing (Phase 3)Active Not RecruitingNCT03164564
What this trial is testing

Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,224
Testing effectiveness (Phase 2)Study completedNCT00920426
What this trial is testing

Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 9
Not applicableUnknownNCT06565013
What this trial is testing

Chemsex Health Evaluation With Extended Release System for HIV Treatment

Who this might be right for
HIV
Clinique Médicale L'Actuel 50
Large-scale testing (Phase 3)Looking for participantsNCT05515770
What this trial is testing

The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir

Who this might be right for
HIV Infections
Evandro Chagas National Institute of Infectious Disease 1,200
Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Not applicableStudy completedNCT06159894
What this trial is testing

Implementation of Long-acting Cabotegravir + Rilpivirine Administration Out of "HIV Units".

Who this might be right for
HIV Infections
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 90
Post-approval studies (Phase 4)Looking for participantsNCT06485154
What this trial is testing

Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial

Who this might be right for
HIV Prevention
University of Witwatersrand, South Africa 100
Large-scale testing (Phase 3)Looking for participantsNCT07650916
What this trial is testing

Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

Who this might be right for
HIV Infections
ViiV Healthcare 564
Large-scale testing (Phase 3)Study completedNCT05896748
What this trial is testing

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 94
Early research (Phase 1)Study completedNCT01593046
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 43
Early research (Phase 1)Study completedNCT01756131
What this trial is testing

A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects

Who this might be right for
Infections, Human Immunodeficiency Virus and Herpesviridae
ViiV Healthcare 72
Post-approval studies (Phase 4)Study completedNCT04982445
What this trial is testing

Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)

Who this might be right for
HIV Infections
ViiV Healthcare 44
Next Page